The disease can cause it to become harder and harder to breathe - and it's key you keep an eye out for symptoms ...

Several weeks after reporting positive results for nerandomilast for idiopathic pulmonary fibrosis, Boehringer Ingelheim ...

The experts will assess unblinded data from BEACON-IPF to figure out why a data safety monitoring board recommended ...

If you have a cough and are putting it down to 'just you' or 'that illness' you've had for weeks, you should see a GP, a ...

NEW YORK CITY, NY / ACCESS Newswire / February 18, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of ...

Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five ...

Adults with progressive pulmonary fibrosis met the primary endpoint of absolute change in FVC with 52-week oral nerandomilast ...

Boehringer Ingelheim (BI) has announced positive top-line results from a late-stage study of its investigational ...

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by ...

Pliant Therapeutics (PLRX) stock jumped 21% Thursday after the company issued an update for a Phase 2b clinical study of ...